DVXV vs. IDNA

Last updated Jun 4, 2026

DVXV (WEBs Health Care XLV Defined Volatility ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds - DVXV tracks the Syntax Defined Volatility XLV Index while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. A 0.59 correlation means they provide meaningful diversification when combined. DVXV charges 0.89%/yr vs 0.47%/yr for IDNA.

Performance

DVXV vs. IDNA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in WEBs Health Care XLV Defined Volatility ETF (DVXV) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, DVXV achieves a -6.26% return, which is significantly lower than IDNA's 10.31% return.

DVXV

• 1D: 1.22%
• 1M: 2.40%
• YTD: -6.26%
• 6M: -6.57%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

IDNA

• 1D: 0.73%
• 1M: -2.56%
• YTD: 10.31%
• 6M: 8.52%
• 1Y: 40.87%
• 3Y*: 6.74%
• 5Y*: -8.42%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

DVXV vs. IDNA - Yearly Performance Comparison

	2026 (YTD)	2025
DVXV WEBs Health Care XLV Defined Volatility ETF	-6.26%	21.27%
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund	10.31%	16.93%

Correlation

The correlation between DVXV and IDNA is 0.59, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (All Time) Calculated using the full available price history since Jul 24, 2025	0.59

Return for Risk

DVXV vs. IDNA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IDNA

IDNA Risk / Return Rank: 55
IDNA Sharpe Ratio Rank: 48
IDNA Sortino Ratio Rank: 49
IDNA Omega Ratio Rank: 42
IDNA Calmar Ratio Rank: 76
IDNA Martin Ratio Rank: 61

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DVXV vs. IDNA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for WEBs Health Care XLV Defined Volatility ETF (DVXV) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	DVXV	IDNA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	1.68	—
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	-0.30	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.75	0.10	+0.65

Drawdowns

DVXV vs. IDNA - Drawdown Comparison

The maximum DVXV drawdown since its inception was -14.36%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for DVXV and IDNA.

Drawdown Indicators

	DVXV	IDNA	Difference
Max Drawdown Largest peak-to-trough decline	-14.36%	-68.26%	+53.90%
Max Drawdown (1Y) Largest decline over 1 year	—	-10.66%	—
Max Drawdown (3Y) Largest decline over 3 years	—	-29.73%	—
Max Drawdown (5Y) Largest decline over 5 years	—	-68.26%	—
Current Drawdown Current decline from peak	-10.72%	-45.61%	+34.89%
Average Drawdown Average peak-to-trough decline	-4.79%	-36.24%	+31.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	3.73%	—

Volatility

Volatility by Period

	DVXV	IDNA	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	7.18%	—
Volatility (6M) Calculated over the trailing 6-month period	—	17.98%	—
Volatility (1Y) Calculated over the trailing 1-year period	21.33%	24.48%	-3.15%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	21.33%	28.42%	-7.09%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.33%	29.53%	-8.20%

DVXV vs. IDNA - Expense Ratio Comparison

DVXV has a 0.89% expense ratio, which is higher than IDNA's 0.47% expense ratio.

Dividends

DVXV vs. IDNA - Dividend Comparison

DVXV has not paid dividends to shareholders, while IDNA's dividend yield for the trailing twelve months is around 1.07%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019
DVXV WEBs Health Care XLV Defined Volatility ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund	1.07%	1.18%	0.98%	1.04%	0.54%	0.70%	0.26%	0.80%

Frequently Asked Questions

Can I hold both DVXV and IDNA in my portfolio?

DVXV and IDNA have a correlation of 0.59, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, DVXV or IDNA?

On fees, IDNA is cheaper at 0.47% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, DVXV or IDNA?

IDNA is cheaper with a 0.47% expense ratio, compared with 0.89% for DVXV.

Which ETF pays a higher dividend yield, DVXV or IDNA?

IDNA has the higher dividend yield at 1.07%, compared with 0.00% for DVXV.

What is the main difference between DVXV and IDNA?

DVXV tracks Syntax Defined Volatility XLV Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: WEBs and iShares. Their fees differ too: 0.89% for DVXV and 0.47% for IDNA.